Related Experiment Video
Updated: Aug 19, 2026

Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice
Published on: February 18, 2015
Rechallenge of patients who developed oral candidiasis or hoarseness with beclomethasone dipropionate
Abstract:
Of 158 asthmatic patients who were placed on inhaled beclomethasone, 15 (9.5%) developed either hoarseness (8), oral thrush (6), or both (1). When their adverse reactions subsided, seven of these 15 patients were rechallenged with inhaled beclomethasone. These included five cases who developed hoarseness and three who developed Candidiasis. One patient had both. Oral thrush did not recur, but 60% (3/5) of patients with hoarseness had recurrence. We conclude that patients may be restarted on inhaled beclomethasone when clinically indicated; however, because of the high recurrence rate, patients who develop hoarseness should not be re-challenged. Concomitant use of oral prednisone and topical beclomethasone may increase the risk of developing hoarseness or candidiasis.
Insights
Inhaled beclomethasone caused hoarseness or oral thrush in 9.5% of asthma patients. Hoarseness recurred in 60% upon re-challenge, suggesting caution when restarting this medication.
Area of Science:
- Pulmonology
- Pharmacology
Background:
- Inhaled corticosteroids are a cornerstone of asthma management.
- Adverse effects of inhaled beclomethasone, though generally mild, can impact patient adherence and treatment efficacy.
Purpose of the Study:
- To investigate the incidence and recurrence of adverse reactions, specifically hoarseness and oral thrush, associated with inhaled beclomethasone in asthmatic patients.
- To evaluate the safety of re-challenging patients with inhaled beclomethasone after experiencing adverse events.
Main Methods:
- A cohort of 158 asthmatic patients receiving inhaled beclomethasone was monitored for adverse events.
- Patients who developed hoarseness or oral thrush had their treatment paused until symptoms resolved.
- A subset of these patients underwent re-challenge with inhaled beclomethasone to assess reaction recurrence.
Main Results:
- 9.5% (15/158) of patients developed hoarseness, oral thrush, or both.
- Upon re-challenge, oral thrush did not recur in any patients.
- Hoarseness recurred in 60% (3/5) of patients who had previously experienced this side effect.
Conclusions:
- While inhaled beclomethasone can cause hoarseness and oral thrush, patients may be restarted on the medication if clinically indicated.
- Due to a high recurrence rate, re-challenging patients with inhaled beclomethasone after developing hoarseness is not recommended.
- Concomitant use of oral prednisone and topical beclomethasone may increase the risk of these adverse events.
Related Concept Videos
Allergic Drug Reactions
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids
Inhaled Medications
Candidiasis
Asthma III: Clinical Manifestations

